Marshall Islands vs Viet Nam: Hepatitis B surface antigen (HBsAg) prevalence
Marshall Islands
0.9%
in 2024
Viet Nam
0.9%
in 2024
Marshall Islands rank
36th
Viet Nam rank
36th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Marshall Islands
- Viet Nam
How they compare
Marshall Islands currently reports 0.9% against 0.9% in Viet Nam, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Viet Nam ahead.
Marshall Islands ranks 36th and Viet Nam ranks 36th of 194 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | Viet Nam | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.4% | 1.2% | 0.2% | Marshall Islands |
| 2020s | 1.0% | 1.0% | 0.0% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Marshall Islands or Viet Nam?
- Marshall Islands, at 0.9% against 0.9% in Viet Nam as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Marshall Islands and Viet Nam?
- 0.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Viet Nam?
- 10 years are reported by both, from 2015 to 2024.
- How do Marshall Islands and Viet Nam rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Marshall Islands ranks 36th and Viet Nam ranks 36th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.